MediCA group has been acquired by Repharm
CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.
MediCA group is present in all levels of the healthcare system with primary, specialist and hospital care being the core business areas. Primary and selected specialist care services are provided in 30 clinics across Lithuania under the brand name MediCA. Kardiolitos Klinikos, which is the only private hospital in Lithuania, has three specialist centers, located in Vilnius, Kaunas, and Šiauliai, providing inpatient and outpatient healthcare services and is a nationally acknowledged center of excellence for cardiology services.
Repharm is a Latvian group of companies providing a wide range of healthcare services, from healthy lifestyle counseling to diagnosis and treatment. The group includes Sentor Farm Aptiekas (pharmacies operating under the Mēness Aptieka brand), Veselības Centru Apvienība (a chain of private clinics), Centrālā Laboratorija (a medical laboratory), Rīgas farmaceitiskā fabrika (a manufacturer of galenic preparations, soft pharmaceuticals and herbal drugs and teas) and Recipe Plus (wholesale trader of pharmaceutical and healthcare products).
Oaklins’ team in Lithuania advised CGP Management on the sale of MediCA group to Repharm.
Alvydas Barsteiga
Member of the Board, CGP Management
Falar com a equipa da transação
Transações relacionadas
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Saber maisbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Saber maisBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Saber mais